Anticancer Drug Market is Expected to Reach a Valuation of USD 137.6 Billion by 2035, Growing at a CAGR of 3.8% During the Forecast Period 2026 - 2035 | Wiseguy Reports

Globally, cancer is the 2nd leading cause of death. Know more about top 10 anticancer drugs in India for the most common cancers.

A review in Medical Oncology evaluates zinc oxide nanostructures, modification strategies, and anticancer mechanisms across fourteen human organ cancer models.

Paclitaxel is a highly valuable diterpenoid anticancer drug originally extracted from the yew tree. Here the authors genetically engineer the moss, Physcomitrium patens, for de novo paclitaxel biosynt...

Deoxysphingolipids can exert anticancer effects; however, their impact on antitumor immunity is not known. Here, we show that inducing deoxysphingolipid accumulation in cancer cells activates the cGAS-STING pathway, leading to immune-mediated tumor suppression.

The Editor-in-Chief of AMB Express has officially retracted a 2020 article investigating the anticancer effects of maslinic acid in human neuroblastoma cells.

A new study published today in the journal Molecules finds that cannabidiol (CBD) enhances the cancer-cell-killing effects of an experimental anticancer compound while reducing its … Continue reading

SEOUL, South Korea, Nov. 7, 2026 /PRNewswire/ — Cancer drugs keep improving, but their limits remain. When antibody therapies first emerged, only a fraction of patients benefited, and small-molecule anticancer drugs often carry severe toxicity. Rather than developing a new anticancer drug, Park Shin-young, CEO of VS Pharmtech (https://www.vspharmtech.com/), has focused on an “anticancer efficacy enhancer” […]

https://twitter.com/GlobeEyeNews/status/2114331186931921082 True, but the headline overstates what has been achieved. Researchers at Japan's RIKEN institute developed an experimental system that uses excess carbon monoxide naturally produced by cancer cells to manufacture a toxic anticancer compound

PDF | Hericium coralloides is a remarkable mushroom valued for both culinary applications and potential health benefits. This study represents its first... | Find, read and cite all the research you n...

Humana (HUM), Evolent (EVH) and American Oncology Network launched a cancer care model at AON clinics across eight states. The model removes traditional prior authorization requests for most anticancer drug therapies at participating practices that demonstrate adherence to established quality and evidence-based treatment standards.Evolent supports the model with oncology clinical pathways, quality improvement programs and provider performance reporting. AON practices are participating in initiatives such as periodic testing of patients receiving immunotherapy to assess continued response. Electronic health record reminders, provider education and performance scorecards aim to increase adoption. Providers also receive a platform powered by Meaningful Insights Biotech Analytics that uses real-time health record data to guide personalized treatment plans.

Read the full paper: Photodynamic and Cytotoxic Evaluation of <i>Euphorbia anacampseros</i> Methanolic Extract: Chemical Characterization, Molecular Docking, and Light‐Activated Anticancer Activity